Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 69.50B | 58.97B | 68.46B | 55.76B | 42.21B |
Gross Profit | 25.97B | 20.57B | 28.41B | 23.08B | 16.35B |
EBITDA | 24.71B | 18.24B | 24.42B | 19.49B | 14.76B |
Net Income | 11.62B | 8.34B | 14.13B | 10.89B | 6.81B |
Balance Sheet | |||||
Total Assets | 141.50B | 133.74B | 113.53B | 92.01B | 76.03B |
Cash, Cash Equivalents and Short-Term Investments | 31.30B | 31.47B | 23.41B | 24.36B | 25.71B |
Total Debt | 20.00B | 20.00B | 24.82M | 19.77M | 21.87M |
Total Liabilities | 37.45B | 38.72B | 26.03B | 16.71B | 9.86B |
Stockholders Equity | 104.05B | 95.03B | 87.50B | 75.30B | 66.17B |
Cash Flow | |||||
Free Cash Flow | 4.38B | -10.52B | 291.18M | 577.39M | 10.61B |
Operating Cash Flow | 22.73B | 7.06B | 13.93B | 10.20B | 12.82B |
Investing Cash Flow | -20.57B | -18.58B | -13.42B | -9.38B | -2.62B |
Financing Cash Flow | -2.41B | 17.66B | -2.12B | -2.88B | -1.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥159.48B | 13.47 | 1.57% | 12.70% | 34.96% | ||
78 Outperform | ¥185.94B | 13.20 | 2.40% | 3.26% | -13.75% | ||
77 Outperform | ¥101.43B | 11.18 | 3.60% | 8.18% | 28.35% | ||
74 Outperform | €217.53B | 12.16 | 7.16% | 4.35% | 8.14% | 274.53% | |
74 Outperform | ¥164.86B | 15.60 | 5.09% | 4.21% | 1.45% | -20.28% | |
70 Outperform | ¥179.96B | 11.27 | 5.69% | 3.08% | 2.68% | -12.79% | |
54 Neutral | ¥190.79B | 15.29 | -3.41% | 4.52% | 0.61% | -180.24% |
Fuso Chemical Co., Ltd. has completed the allotment procedure for the disposal of treasury stock as restricted stock compensation, which was resolved at a Board of Directors meeting on July 15, 2025. This disposal involves 8,595 shares of the company’s common stock, valued at 4,000 yen per share, and is intended as compensation for the company’s directors, excluding audit, supervisory, and external board directors.
Fuso Chemical Co., Ltd. reported a 7% increase in net sales for the three months ending June 30, 2025, compared to the same period in the previous year. Despite a decrease in comprehensive income, the company showed growth in operating profit and profit attributable to owners, indicating a positive operational performance. The financial outlook for the year ending March 31, 2026, suggests a slight increase in net sales but a decrease in profits, reflecting potential challenges in maintaining profit margins.
Fuso Chemical Co., Ltd. has announced the disposal of treasury stock as part of a Restricted Stock Compensation Plan aimed at providing incentives for its directors to increase corporate value. This move aligns the interests of directors with shareholders and involves the allotment of 8,595 shares to seven directors, with specific conditions set for the transfer and acquisition of these shares.